Smith CP, Bores GM, Petko W, Li M, Selk DE, Rush DK, Camacho F, Winslow JT, Fishkin R, Cunningham DM, Brooks KM, Roehr J, Hartman HB, Davis L, Vargas HM (1997) <br />Pharmacological activity and safety profile of P10358, a novel, orally active acetylcholinesterase inhibitor for Alzheimer's disease<br /><i>Journal of Pharmacology & Experimental Therapeutics</i> <b>280</b>: 710<br /><br />Bores GM, Huger FP, Petko W, Mutlib AE, Camacho F, Rush DK, Selk DE, Wolf V, Kosley RW, Jr., Davis L, Vargas HM (1996) <br />Pharmacological evaluation of novel Alzheimer's disease therapeutics: acetylcholinesterase inhibitors related to galanthamine<br /><i>Journal of Pharmacology & Experimental Therapeutics</i> <b>277</b>: 728<br /><br />Fink DM, Bores GM, Effland RC, Huger FP, Kurys BE, Rush DK, Selk DE (1995) <br />Synthesis and evaluation of 5-amino-5,6,7,8-tetrahydroquinolinones as potential agents for the treatment of Alzheimer's disease<br /><i>Journal of Medicinal Chemistry</i> <b>38</b>: 3645<br /><br />Shutske GM, Tomer JD, Kapples KJ, Hrib NJ, Jurcak JG, Bores GM, Huger FP, Petko W, Smith CP (1992) <br />Aminopyridine carbamic acid esters: synthesis and potential as acetylcholinesterase inhibitors and acetylcholine releasers<br /><i>J Pharm Sci</i> <b>81</b>: 380<br /><br />Shutske GM, Pierrat FA, Kapples KJ, Cornfeldt ML, Szewczak MR, Huger FP, Bores GM, Haroutunian V, Davis KL (1989) <br />9-Amino-1,2,3,4-tetrahydroacridin-1-ols: synthesis and evaluation as potential Alzheimer's disease therapeutics<br /><i>Journal of Medicinal Chemistry</i> <b>32</b>: 1805<br /><br />Shutske GM, Pierrat FA, Cornfeldt ML, Szewczak MR, Huger FP, Bores GM, Haroutunian V, Davis KL (1988) <br />(+/-)-9-Amino-1,2,3,4-tetrahydroacridin-1-ol. A potential Alzheimer's disease therapeutic of low toxicity<br /><i>Journal of Medicinal Chemistry</i> <b>31</b>: 1278<br /><br />